CIFI
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Aug 2022)
What this means for you
This application is over — abandoned 22 Aug 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90294501
- Mark type
- Stylized text
- Filed
- 02 Nov 2020
- Published for opposition
- 25 May 2021
- Abandoned
- 22 Aug 2022
- Attorney of record
- Samantha C. Markley
Goods and services
- Class 001 — Chemicals: Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprising enzymes for scientific and research purposes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Reagents for scientific and research use for amplification of DNA; Reagent kits for amplification of DNA comprising at least one of enzymes, buffers, and nucleic acids for use in biotechnology fields for scientific and research purposes; Reagents for scientific and research use for use in nucleic acid sequencing for scientific and research purposes; Kits for use in nucleic acid sequencing, namely, kits for molecular biology and cell biology applications comprised of at least one of enzymes, buffers, and nucleic acids for scientific and research purposes; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes; diagnostic preparations for humans for medical purposes; diagnostic preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
- Class 042 — Scientific and technological services: Scientific research services, namely, gene analysis and sequencing as well as DNA analysis and sequencing; scientific research services, namely, preparation of materials for gene analysis and sequencing as well as DNA analysis and sequencing
- Class 044 — Medical, beauty and agricultural services: Gene analysis and sequencing as well as DNA analysis and sequencing for medical diagnostic purposes; gene analysis and sequencing as well as DNA analysis and sequencing for use in cancer diagnosis and treatment
Owner
- Arima Genomics Inc., San Diego, CA, US
- Arima Genomics Inc., San Diego, CA, US
Prosecution history
- 22 Aug 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Aug 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Nov 2021 — SOU EXTENSION 1 GRANTED
- 08 Nov 2021 — SOU EXTENSION 1 FILED
- 08 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 20 Jul 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 May 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 May 2021 — PUBLISHED FOR OPPOSITION
- 05 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Apr 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Apr 2021 — EXAMINER'S AMENDMENT ENTERED
- 15 Apr 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 Apr 2021 — EXAMINERS AMENDMENT E-MAILED
- 15 Apr 2021 — EXAMINERS AMENDMENT -WRITTEN